PRRT2 and cholangiocarcinoma: To globally identify iCCA‐specific oncogenic genes, we thus integrated transcriptome data from three clinical cohorts, including tissues from normal bile ducts as well as tumor and non‐tumor liver tissues from cholangiocarcinoma patients (iCCA, 82%) and HCC patients (Figure 1A).